Correlation Between Vincerx Pharma and Enliven Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vincerx Pharma and Enliven Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vincerx Pharma and Enliven Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vincerx Pharma and Enliven Therapeutics, you can compare the effects of market volatilities on Vincerx Pharma and Enliven Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vincerx Pharma with a short position of Enliven Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vincerx Pharma and Enliven Therapeutics.

Diversification Opportunities for Vincerx Pharma and Enliven Therapeutics

0.8
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Vincerx and Enliven is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding Vincerx Pharma and Enliven Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enliven Therapeutics and Vincerx Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vincerx Pharma are associated (or correlated) with Enliven Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enliven Therapeutics has no effect on the direction of Vincerx Pharma i.e., Vincerx Pharma and Enliven Therapeutics go up and down completely randomly.

Pair Corralation between Vincerx Pharma and Enliven Therapeutics

Given the investment horizon of 90 days Vincerx Pharma is expected to under-perform the Enliven Therapeutics. In addition to that, Vincerx Pharma is 5.09 times more volatile than Enliven Therapeutics. It trades about -0.38 of its total potential returns per unit of risk. Enliven Therapeutics is currently generating about 0.03 per unit of volatility. If you would invest  2,147  in Enliven Therapeutics on November 18, 2024 and sell it today you would earn a total of  21.00  from holding Enliven Therapeutics or generate 0.98% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Vincerx Pharma  vs.  Enliven Therapeutics

 Performance 
       Timeline  
Vincerx Pharma 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Vincerx Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in March 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Enliven Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Enliven Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Vincerx Pharma and Enliven Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vincerx Pharma and Enliven Therapeutics

The main advantage of trading using opposite Vincerx Pharma and Enliven Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vincerx Pharma position performs unexpectedly, Enliven Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enliven Therapeutics will offset losses from the drop in Enliven Therapeutics' long position.
The idea behind Vincerx Pharma and Enliven Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

Share Portfolio
Track or share privately all of your investments from the convenience of any device
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing